Specialists from Johns Hopkins and Harvard Universities evaluated children diagnosed with Ataxia-Telangiectasia (AT), a rare genetic disorder, at healthcare institutions in Istanbul. This significant meeting marked a step forward in the potential application of advanced treatment methods in Turkey.